{"id":"adipose-derived-mesenchymal-stem-cells","safety":{"commonSideEffects":[{"rate":null,"effect":"Infection"},{"rate":null,"effect":"Local pain"}]},"_chembl":{"chemblId":"CHEMBL5315108","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"featherless-qwen","explanation":"These cells secrete various growth factors and cytokines that can reduce inflammation, promote angiogenesis, and support the regeneration of damaged tissues. They also have the potential to differentiate into osteocytes, chondrocytes, and adipocytes, contributing to tissue healing and regeneration.","oneSentence":"Adipose-derived mesenchymal stem cells modulate immune responses and promote tissue repair through paracrine signaling and differentiation into multiple cell types.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T03:19:25.678Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Orthopedic injuries"},{"name":"Autoimmune diseases"},{"name":"Wound healing"}]},"trialDetails":[{"nctId":"NCT06905834","phase":"PHASE2","title":"Evaluation of Allogenic Mesenchymal Stem Cell (MSC) Injection Therapy for Refractory Graft-versus-Host Disease (GVHD) Unresponsive to Conventional Treatments","status":"NOT_YET_RECRUITING","sponsor":"Instituto de Investigación Biomédica de Salamanca","startDate":"2026-05","conditions":"Dry Eye Disease (DED), Graft-Versus-Host Disease(GVHD)","enrollment":30},{"nctId":"NCT06798623","phase":"PHASE1","title":"Anterior Cruciate Ligament (ACL) Reconstruction With Autologous Fat Pad Derived Mesenchymal Stem Cells","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2026-03-24","conditions":"Anterior Cruciate Ligament Reconstruction","enrollment":15},{"nctId":"NCT07487467","phase":"NA","title":"Autologous SVF Therapy for Type 2 Diabetes","status":"RECRUITING","sponsor":"Kaiser Clinic and Hospital","startDate":"2025-01-20","conditions":"Diabetes Mellitus, Type 2","enrollment":10},{"nctId":"NCT07048314","phase":"PHASE1, PHASE2","title":"Stem Cells for Erectile Dysfunction Post RALP","status":"NOT_YET_RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2026-03-10","conditions":"Erectile Dysfunction, Prostate Cancer","enrollment":40},{"nctId":"NCT07474467","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars","status":"NOT_YET_RECRUITING","sponsor":"CellinCells","startDate":"2026-08-01","conditions":"Atrophic Scar","enrollment":31},{"nctId":"NCT07238062","phase":"","title":"\"An Intermediate Size Patient Population Expanded Access Protocol to Evaluate the Safety and Efficacy of Allogeneic HB-adMSCs (Hope Biosciences - Adipose Derived Mesenchymal Stem Cells) for the Treatment of Multiple System Atrophy.\"","status":"TEMPORARILY_NOT_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Multiple System Atrophy","enrollment":""},{"nctId":"NCT03268603","phase":"PHASE2","title":"Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2017-10-10","conditions":"ALS, Amyotrophic Lateral Sclerosis","enrollment":75},{"nctId":"NCT06654193","phase":"PHASE1, PHASE2","title":"Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury","status":"RECRUITING","sponsor":"Hope Biosciences LLC","startDate":"2026-02-01","conditions":"Acute Kidney Injury","enrollment":70},{"nctId":"NCT07077746","phase":"PHASE2","title":"HB-adMSCs for the Treatment of Crohn's Disease","status":"RECRUITING","sponsor":"Hope Biosciences Research Foundation","startDate":"2026-03","conditions":"Crohn Disease (CD)","enrollment":46},{"nctId":"NCT07377838","phase":"PHASE3","title":"Study of ADSTEM Injection for Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis","status":"NOT_YET_RECRUITING","sponsor":"EHL Bio Co., Ltd.","startDate":"2026-06","conditions":"Atopic Dermatitis","enrollment":286},{"nctId":"NCT06840275","phase":"PHASE2","title":"ASCs in Recently Diagnosed Non-ischemic Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Cell to Cure ApS","startDate":"2026-03-01","conditions":"Non-Ischemic Heart Failure, Reduced Ejection Fraction Heart Failure","enrollment":90},{"nctId":"NCT05553132","phase":"PHASE1","title":"A Study of REcycled CartiLage Auto/Allo IMplantation to Treat and Repair Focal Hip Cartilage Defects","status":"ACTIVE_NOT_RECRUITING","sponsor":"Daniel B. F. Saris","startDate":"2023-08-08","conditions":"Cartilage Defect","enrollment":15},{"nctId":"NCT06775964","phase":"PHASE1, PHASE2","title":"Stem Cell Therapy for Early Alzheimer's Disease","status":"RECRUITING","sponsor":"Paul E Schulz","startDate":"2026-02","conditions":"Cognitive Dysfunction","enrollment":12},{"nctId":"NCT07367815","phase":"PHASE1, PHASE2","title":"Allogeneic Adipose Tissue Derived-stem Cells in Alzheimer Disease","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2026-03-01","conditions":"Alzheimer Disease","enrollment":9},{"nctId":"NCT06726538","phase":"PHASE1, PHASE2","title":"Investigating the Efficacy of Autologous, Adipose-derived Mesenchymal Stem Cell Therapy for the Treatment of Sexual Function Impairment in Women Aged 40-50","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2023-10-01","conditions":"Female Sexual Dysfunction","enrollment":50},{"nctId":"NCT04312113","phase":"PHASE1","title":"Angiographic Delivery of AD-MSC for Ulcerative Colitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2020-11-16","conditions":"Ulcerative Colitis","enrollment":20},{"nctId":"NCT04063215","phase":"PHASE1, PHASE2","title":"A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy","status":"COMPLETED","sponsor":"Hope Biosciences LLC","startDate":"2020-01-01","conditions":"Traumatic Brain Injury","enrollment":24},{"nctId":"NCT07344324","phase":"NA","title":"Study Evaluating the Safety and Feasibility of Endoscopic Duodenal Injections of Autologous Mesenchymal Stem Cells","status":"NOT_YET_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2026-02-02","conditions":"Diabete Type 2, Insulin Resistant Diabetes (Mellitus), Obesity","enrollment":15},{"nctId":"NCT06623240","phase":"PHASE2","title":"HB-adMSCs vs Placebo for the Treatment of Juvenile Idiopathic Arthritis","status":"WITHDRAWN","sponsor":"Hope Biosciences Research Foundation","startDate":"2026-01","conditions":"Juvenile Idiopathic Arthritis (JIA)","enrollment":""},{"nctId":"NCT02808208","phase":"PHASE1","title":"Autologous Adipose Derived Mesenchymal Stem Cells (AMSC) in Reducing Hemodialysis Arteriovenous Fistula Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2017-06-07","conditions":"End Stage Renal Disease (ESRD), Vascular Access Complication","enrollment":74},{"nctId":"NCT04995081","phase":"PHASE2","title":"Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD)","status":"COMPLETED","sponsor":"Hope Biosciences Research Foundation","startDate":"2021-07-16","conditions":"Parkinson Disease","enrollment":60},{"nctId":"NCT05595681","phase":"PHASE1","title":"Effect of Mesenchymal Stem Cells on Healing of Foot Ulcers in Diabetes Patients.","status":"TERMINATED","sponsor":"Cell to Cure ApS","startDate":"2022-12-15","conditions":"Diabetic Foot Ulcer, Mesenchymal Stromal Cells","enrollment":21},{"nctId":"NCT07290946","phase":"PHASE2","title":"Repeated Mesenchymal Stem Cell Therapy for Radiation-Induced Hyposalivation and Xerostomia in Head and Neck Cancer Survivors","status":"NOT_YET_RECRUITING","sponsor":"Christian von Buchwald","startDate":"2025-12","conditions":"Xerostomia Due to Hyposecretion of Salivary Gland, Xerostomia Due to Radiotherapy, Sjögren´s Syndrome","enrollment":100},{"nctId":"NCT07164482","phase":"","title":"Intermediate Size Patient Population Expanded Access Protocol to Evaluate HB-adMSCs for the Treatment of Patients With Traumatic or Nontraumatic Brain Injury","status":"AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Brain Injury","enrollment":""},{"nctId":"NCT02068794","phase":"PHASE1, PHASE2","title":"MV-NIS Infected Mesenchymal Stem Cells in Treating Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2014-04-25","conditions":"Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma","enrollment":34},{"nctId":"NCT03608579","phase":"PHASE1","title":"Autologous Culture Expanded Adipose Derived MSCs for Treatment of Painful Hip OA","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2018-11-05","conditions":"Osteoarthritis, Hip","enrollment":24},{"nctId":"NCT05789394","phase":"PHASE1","title":"Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2023-06-16","conditions":"Recurrent Glioblastoma, IDH-Wildtype, Recurrent Astrocytoma, IDH-Mutant, Grade 4, Astrocytoma, Grade IV","enrollment":20},{"nctId":"NCT04520373","phase":"PHASE2","title":"Autologous Adipose Derived Mesenchymal Stem Cells for Spinal Cord Injury Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2020-06-25","conditions":"Spinal Cord Injuries, Paralysis","enrollment":40},{"nctId":"NCT02838069","phase":"PHASE2","title":"A Study Evaluating the Efficacy of a Single Injection Autologous Adipose Derived Mesenchymal Stromal Cells in Patients With Knee Osteoarthritis","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2016-09-20","conditions":"Osteoarthritis","enrollment":100},{"nctId":"NCT05154851","phase":"","title":"HBCMD01- Expanded Access for the Treatment of Congenital Muscular Dystrophy.","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Congenital Muscular Dystrophy Due to Lamin A/C Mutation","enrollment":""},{"nctId":"NCT04825613","phase":"","title":"\"Individual Patient Expanded Access IND to Treat Primary Lateral Sclerosis\"","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Primary Lateral Sclerosis, Adult, 1","enrollment":""},{"nctId":"NCT04064957","phase":"","title":"Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Spinal Cord Injury","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Spinal Cord Injuries","enrollment":""},{"nctId":"NCT04029896","phase":"","title":"Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for the Treatment of Cerebral Palsy","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Cerebral Palsy","enrollment":""},{"nctId":"NCT04087889","phase":"","title":"Individual Patient Expanded Access IND of Hope Biosciences First Blood Relative Allogeneic Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) for Pancreatic Cancer","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences LLC","startDate":"","conditions":"Pancreatic Cancer","enrollment":""},{"nctId":"NCT04825626","phase":"","title":"An Expanded Access IND for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Chronic Inflammatory Demyelinating Polyneuropathy","enrollment":""},{"nctId":"NCT04604288","phase":"","title":"Individual Patient Expanded Access IND of Autologous HB-adMSCS for the Treatment of Bilateral Knee Pain.","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Knee Pain Chronic, Osteo Arthritis Knee","enrollment":""},{"nctId":"NCT06056427","phase":"","title":"Intermediate Size Expanded Access Protocol Using Autologous HB-adMSCs for the Treatment of Parkinson's Disease","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Parkinson Disease","enrollment":""},{"nctId":"NCT05951777","phase":"PHASE2","title":"Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury","status":"RECRUITING","sponsor":"Hope Biosciences LLC","startDate":"2024-04-16","conditions":"Traumatic Brain Injury","enrollment":51},{"nctId":"NCT04772378","phase":"","title":"Intermediate Size Patient Population Expanded Access IND for the Treatment of Patients With Parkinson's Disease.","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Parkinson Disease","enrollment":""},{"nctId":"NCT04612465","phase":"PHASE3","title":"Clinical Study to Evaluate Efficacy and Safety of ASC and Fibringlue or Fibringlue in Patients With Crohn's Fistula","status":"ACTIVE_NOT_RECRUITING","sponsor":"Anterogen Co., Ltd.","startDate":"2020-01-09","conditions":"Crohn's Fistula","enrollment":46},{"nctId":"NCT04514952","phase":"","title":"Individual Patient Expanded Access IND of Autologous HBadMSCs for the Treatment of Amyotrophic Lateral Sclerosis","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Amyotrophic Lateral Sclerosis","enrollment":""},{"nctId":"NCT04064983","phase":"","title":"Individual Patient Expanded Access IND to Treat Polyneuropathy","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Polyneuropathies","enrollment":""},{"nctId":"NCT04228666","phase":"PHASE1, PHASE2","title":"A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's Disease","status":"WITHDRAWN","sponsor":"Hope Biosciences LLC","startDate":"2020-03-01","conditions":"Alzheimer Disease","enrollment":""},{"nctId":"NCT03925649","phase":"","title":"Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Treatment of SCI","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences LLC","startDate":"","conditions":"Spinal Cord Injury at C5-C7 Level","enrollment":""},{"nctId":"NCT04798066","phase":"","title":"Intermediate Size Expanded Access Protocol for the Treatment of Post-COVID-19 Syndrome","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Post COVID-19 Syndrome","enrollment":""},{"nctId":"NCT04711811","phase":"","title":"Individual Patient Expanded Access IND of HB-adMSCs for Chronic Musculoskeletal Pain.","status":"NO_LONGER_AVAILABLE","sponsor":"Hope Biosciences Research Foundation","startDate":"","conditions":"Chronic Pain","enrollment":""},{"nctId":"NCT04348435","phase":"PHASE2","title":"A Randomized, Double-Blind, Single Center, Efficacy and Safety Study of Allogeneic HB-adMSCs Against COVID-19.","status":"COMPLETED","sponsor":"Hope Biosciences Research Foundation","startDate":"2020-05-14","conditions":"COVID-19","enrollment":53},{"nctId":"NCT05116540","phase":"PHASE2","title":"Randomized Double-Blind Phase 2 Efficacy and Safety of Autologous HB-MSCs vs Placebo for Treatment of Multiple Sclerosis","status":"COMPLETED","sponsor":"Hope Biosciences Research Foundation","startDate":"2021-11-24","conditions":"Multiple Sclerosis","enrollment":24},{"nctId":"NCT05126563","phase":"PHASE2","title":"Randomized Double-Blind Phase 2 Study of Allogeneic HB-adMSCs for the Treatment of Chronic Post-COVID-19 Syndrome","status":"COMPLETED","sponsor":"Hope Biosciences Research Foundation","startDate":"2022-02-02","conditions":"Post COVID-19 Syndrome","enrollment":79},{"nctId":"NCT04362189","phase":"PHASE2","title":"Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19","status":"TERMINATED","sponsor":"Hope Biosciences Research Foundation","startDate":"2020-06-30","conditions":"COVID-19","enrollment":48},{"nctId":"NCT04349631","phase":"PHASE2","title":"A Clinical Trial to Determine the Safety and Efficacy of HB-adMSCs to Provide Protection Against COVID-19","status":"COMPLETED","sponsor":"Hope Biosciences Research Foundation","startDate":"2020-04-20","conditions":"COVID-19","enrollment":51},{"nctId":"NCT04928287","phase":"PHASE2","title":"Randomized, Double-Blind Clinical Trial for Parkinson's Disease (Early and Moderate)","status":"COMPLETED","sponsor":"Hope Biosciences Research Foundation","startDate":"2021-06-28","conditions":"Parkinson Disease","enrollment":24},{"nctId":"NCT03691909","phase":"PHASE1, PHASE2","title":"Phase 1/2a Clinical Trial to Assess the Safety of HB-adMSCs for the Treatment of Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Hope Biosciences LLC","startDate":"2018-09-25","conditions":"Rheumatoid Arthritis","enrollment":15},{"nctId":"NCT04569409","phase":"PHASE3","title":"Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers.","status":"COMPLETED","sponsor":"Anterogen Co., Ltd.","startDate":"2020-07-14","conditions":"Diabetic Foot Ulcer","enrollment":104},{"nctId":"NCT06539429","phase":"PHASE1","title":"Clinical Study to Evaluate Efficacy and Safety of ANT-301 in Patients With Knee Osteoarthritis in Grade III/IV by K/L","status":"ACTIVE_NOT_RECRUITING","sponsor":"Anterogen Co., Ltd.","startDate":"2024-10-22","conditions":"Osteoarthritis, Knee","enrollment":6},{"nctId":"NCT07183384","phase":"PHASE1, PHASE2","title":"MSC Exosome Therapy for Post-Preeclampsia Endothelial Dysfunction","status":"RECRUITING","sponsor":"Universitas Padjadjaran","startDate":"2024-07-01","conditions":"Preeclampsia, Postpartum, Endothelial Injury","enrollment":80},{"nctId":"NCT07106229","phase":"PHASE3","title":"A Study to Investigate the Effectiveness, Safety, and Tolerability of MAG200 Solution for Intra-articular Injection Compared With Placebo in Participants Aged 35 to 75 Years of Age With Symptomatic Osteoarthritis of the Knee.","status":"NOT_YET_RECRUITING","sponsor":"Magellan Stem Cells","startDate":"2025-11","conditions":"Knee Osteoarthristis","enrollment":573},{"nctId":"NCT05344157","phase":"PHASE1, PHASE2","title":"A First-in-Human Study of XSTEM-OA in Patients With Knee Osteoarthritis","status":"COMPLETED","sponsor":"Xindu Pty Ltd","startDate":"2022-06-22","conditions":"Osteoarthritis, Knee","enrollment":24},{"nctId":"NCT07137130","phase":"NA","title":"Secretome TGF Beta 3","status":"NOT_YET_RECRUITING","sponsor":"Indonesia University","startDate":"2026-02-14","conditions":"Melasma","enrollment":34},{"nctId":"NCT06789302","phase":"PHASE2","title":"A Double-Blind, Randomized, Placebo-Controlled Phase IIa Clinical Trial to Evaluate the Safety and Efficacy of DT2-SCT in Subjects With Type 2 Diabetes Mellitus","status":"NOT_YET_RECRUITING","sponsor":"Global Institute of Stem Cell Therapy and Research","startDate":"2025-12","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":120},{"nctId":"NCT05308836","phase":"PHASE1","title":"Evaluate Safety of Adipose Derived Mesenchymal Stem Cell Transplantation for Type 1 Diabetes Treatment","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2021-05-04","conditions":"Type 1 Diabetes","enrollment":10},{"nctId":"NCT03840343","phase":"PHASE1","title":"Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2019-10-23","conditions":"Diabetic Kidney Disease, Diabetic Nephropathies, Diabetes Mellitus, Type 2","enrollment":2},{"nctId":"NCT04392206","phase":"PHASE1","title":"AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses","status":"RECRUITING","sponsor":"Houssam Farres, M.D.","startDate":"2020-05-15","conditions":"End Stage Renal Disease","enrollment":15},{"nctId":"NCT06210919","phase":"PHASE1","title":"Safety and Tolerability of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars","status":"COMPLETED","sponsor":"CellinCells","startDate":"2023-12-06","conditions":"Atrophic Scar","enrollment":3},{"nctId":"NCT04368806","phase":"PHASE2, PHASE3","title":"A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis","status":"RECRUITING","sponsor":"Nature Cell Co. Ltd.","startDate":"2021-05-26","conditions":"Osteoarthritis, Knee","enrollment":140},{"nctId":"NCT06570291","phase":"PHASE3","title":"Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis","status":"RECRUITING","sponsor":"Wuxi Cellular Biopharmaceutical Group Ltd.","startDate":"2025-02-28","conditions":"Knee Osteoarthritis","enrollment":520},{"nctId":"NCT07010926","phase":"PHASE2","title":"A Double-Blind, Randomized, Placebo-Controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of L2-01 in Subjects With Crohn's Disease","status":"NOT_YET_RECRUITING","sponsor":"L2 Bio, LLC","startDate":"2025-08-15","conditions":"Crohn&Amp;#39;s, Crohn&Amp;#39;s Disease (CD)","enrollment":120},{"nctId":"NCT04869761","phase":"PHASE1","title":"Stem Cell Therapy for Chronic Kidney Disease","status":"COMPLETED","sponsor":"LaTonya J. Hickson","startDate":"2021-10-07","conditions":"Chronic Kidney Diseases, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1","enrollment":10},{"nctId":"NCT05549609","phase":"PHASE1, PHASE2","title":"A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers","status":"RECRUITING","sponsor":"Xintela AB","startDate":"2022-10-26","conditions":"Venous Leg Ulcer","enrollment":6},{"nctId":"NCT06738576","phase":"PHASE1","title":"Allogeneic Use of Expanded Mesenchymal Stem Cells Derived From Adipose Tissue (HC106), Female Urinary Incontinence Women Over 50 Years Old","status":"RECRUITING","sponsor":"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz","startDate":"2024-12-16","conditions":"Urinary Incontinence Stress","enrollment":60},{"nctId":"NCT04466007","phase":"PHASE2","title":"Safety and Efficacy of Allogeneic Adipose Tissue Mesenchymal Stem Cells in Diabetic Patients With Critical Limb Ischemia","status":"COMPLETED","sponsor":"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz","startDate":"2021-01-11","conditions":"Limb Ischemia, Diabetic Foot","enrollment":90},{"nctId":"NCT06280092","phase":"EARLY_PHASE1","title":"Allogenic Adipose-derived Mesenchymal Stem Cells(AMSCs) for Epilepsy During Deep Brain Stimulation(DBS) Surgery","status":"RECRUITING","sponsor":"Sanjeet S. Grewal","startDate":"2024-12-23","conditions":"Epilepsy","enrollment":5},{"nctId":"NCT05018793","phase":"PHASE1","title":"Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Versus Cultured Allogeneic Adult Umbilical-cord Derived Mesenchymal Stem Cell Intrathecal Injection for SCI","status":"RECRUITING","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2024-12-01","conditions":"Spinal Cord Injuries","enrollment":15},{"nctId":"NCT05018871","phase":"PHASE1","title":"Safety of Cultured Autologous Adult Adipose Derived Mesenchymal Stem Cell Intravenous Infusion for CP","status":"SUSPENDED","sponsor":"The Foundation for Orthopaedics and Regenerative Medicine","startDate":"2025-12","conditions":"Cerebral Palsy","enrollment":15},{"nctId":"NCT03449082","phase":"PHASE2","title":"Treatment of Intractable Common Extensor Tendon Injury Using Mesenchymal Stem Cells (Allo-ASC)","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2018-03-15","conditions":"Lateral Epicondylitis","enrollment":30},{"nctId":"NCT05521672","phase":"PHASE1, PHASE2","title":"Clinical Trial to Evaluate if the Laparoscopic Administration of Cells Derived From the Fatty Tissue Can Improve the Inflammatory Stenosis in Patient With Crohn's Disease","status":"TERMINATED","sponsor":"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz","startDate":"2022-10-24","conditions":"Stenosis; Bowel, Crohn Disease","enrollment":2},{"nctId":"NCT06843122","phase":"PHASE2","title":"Evaluation of the Safety and Efficacy of Live ASCs in the Treatment of Diabetic Foot (FOOTCELL)","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Warsaw","startDate":"2025-03-08","conditions":"Diabetic Foot Ulcer","enrollment":105},{"nctId":"NCT06649864","phase":"PHASE1","title":"Adipose-Derived Mesenchymal Stem Cell for Preventing Biliary Complications","status":"NOT_YET_RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-02","conditions":"Liver Transplant; Complications, Liver Diseases","enrollment":20},{"nctId":"NCT06805448","phase":"PHASE1, PHASE2","title":"Intraglandular Treatment With Adipose-derived Mesenchymal Stem Cells in Patients With Xerostomia Due to Sjögren's Disease","status":"RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2025-01-21","conditions":"Sjorgren's Syndrome","enrollment":40},{"nctId":"NCT06795620","phase":"PHASE1","title":"Tolerance Study of Allogeneic of Adipose Tissue Derived Mesenchymal Stroma/Stem Cells (AdMSC) Transplantation in Patients With Critical Limb Ischemia.","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2025-01","conditions":"Critical Limb Ischemia","enrollment":10},{"nctId":"NCT03754465","phase":"PHASE2","title":"Clinical Study of ALLO-ASC-SHEET in Subjects with Diabetic Foot Ulcers","status":"COMPLETED","sponsor":"Anterogen Co., Ltd.","startDate":"2019-01-02","conditions":"Diabetic Foot Ulcer","enrollment":66},{"nctId":"NCT05094011","phase":"PHASE1","title":"Evaluating Safety, Tolerability, and Efficacy of Autologous MitoCell Transplantation in Subjects With Idiopathic Parkinson's Disease","status":"NOT_YET_RECRUITING","sponsor":"Taiwan Mitochondrion Applied Technology Co., Ltd.","startDate":"2026-03-01","conditions":"Idiopathic Parkinson's Disease","enrollment":9},{"nctId":"NCT04223622","phase":"","title":"Effects of ASC Secretome on Human Osteochondral Explants","status":"COMPLETED","sponsor":"I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio","startDate":"2021-04-12","conditions":"Osteoarthritis","enrollment":36},{"nctId":"NCT05602116","phase":"PHASE1","title":"ASC - Autism Study","status":"COMPLETED","sponsor":"Cell to Cure ApS","startDate":"2023-06-09","conditions":"Autism Spectrum Disorder, Gastrointestinal Dysfunction, Leaky Gut Syndrome","enrollment":10},{"nctId":"NCT04661644","phase":"PHASE1, PHASE2","title":"Efficacy and Safety of Mesenchymal Stem Cell Clusters in Patients with Critical Limb Ischemia","status":"COMPLETED","sponsor":"S.Biomedics Co., Ltd.","startDate":"2020-11-04","conditions":"Critical Limb Ischemia","enrollment":20},{"nctId":"NCT05362786","phase":"PHASE1","title":"Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease","status":"COMPLETED","sponsor":"LaTonya J. Hickson","startDate":"2022-07-01","conditions":"Chronic Kidney Diseases","enrollment":14},{"nctId":"NCT03672825","phase":"PHASE1","title":"REcycled CartiLage Auto/Allo IMplantation","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2018-09-13","conditions":"Cartilage Defect","enrollment":25},{"nctId":"NCT04544215","phase":"PHASE1, PHASE2","title":"A Clinical Study of Mesenchymal Progenitor Cell Exosomes Nebulizer for the Treatment of Pulmonary Infection","status":"SUSPENDED","sponsor":"Ruijin Hospital","startDate":"2020-07-01","conditions":"Drug-resistant","enrollment":60},{"nctId":"NCT06488898","phase":"PHASE2","title":"Abdominal Aortic Aneurysm Stabilization With Truncal Cells: Controlled Clinical Trial With Historical Cohorts","status":"RECRUITING","sponsor":"Instituto de Investigación Hospital Universitario La Paz","startDate":"2024-06-13","conditions":"Aortic Aneurysm, Abdominal","enrollment":8},{"nctId":"NCT05520086","phase":"PHASE1, PHASE2","title":"Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis.","status":"UNKNOWN","sponsor":"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz","startDate":"2022-11-11","conditions":"Chronic Conjunctivitis, Stevens-Johnson Syndrome, Lyell Syndrome","enrollment":20},{"nctId":"NCT06490887","phase":"","title":"Spine Unit Modelling Coupled With hIgh Throughput Analysis (SUIT)","status":"RECRUITING","sponsor":"I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio","startDate":"2023-06-28","conditions":"Degenerative Disc Disease","enrollment":20},{"nctId":"NCT05933434","phase":"PHASE1, PHASE2","title":"Allogenic Mesenchymal Stem Cell Intraarticular Injection for Knee Osteoarthritis Therapy","status":"RECRUITING","sponsor":"Aarhus University Hospital","startDate":"2024-03-07","conditions":"Knee Osteoarthritis","enrollment":80},{"nctId":"NCT03346967","phase":"PHASE1, PHASE2","title":"Outcomes of Adipose Derived Mesenchymal Stem Cells on Sexual Hormone Deficiency","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2017-11-01","conditions":"Hormone Deficiency","enrollment":30},{"nctId":"NCT05329662","phase":"PHASE2","title":"Adipose Tissue-derived Mesenchymal Stem Cell (AD-MSC) Therapy for the Treatment of Sexual Function Impairment in Female","status":"RECRUITING","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2023-05-01","conditions":"Sexual Dysfunction Female","enrollment":130},{"nctId":"NCT06397274","phase":"PHASE2","title":"Stemchymal® for Polyglutamine Spinocerebellar Ataxia","status":"NOT_YET_RECRUITING","sponsor":"Steminent US, Inc.","startDate":"2025-06-01","conditions":"Spinocerebellar Ataxias","enrollment":20},{"nctId":"NCT04992247","phase":"PHASE2","title":"Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 \"Long Haul\" Pulmonary Compromise","status":"WITHDRAWN","sponsor":"Sorrento Therapeutics, Inc.","startDate":"2024-02","conditions":"Covid19","enrollment":""},{"nctId":"NCT05081921","phase":"PHASE1, PHASE2","title":"Clinical Trial to Evaluate Safety and Efficacy of MesoCellA-Ortho Tissue-Engineered Advanced Therapy Product in Patients With Osteoarthrosis and Civilisation Diseases","status":"COMPLETED","sponsor":"Jagiellonian University","startDate":"2022-01-05","conditions":"Osteoarthritis of Knee","enrollment":192},{"nctId":"NCT04137562","phase":"PHASE2","title":"Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"EHL Bio Co., Ltd.","startDate":"2019-12-11","conditions":"Atopic Dermatitis","enrollment":118},{"nctId":"NCT04289194","phase":"PHASE1, PHASE2","title":"Clinical Study to Assess the Safety and Preliminary Efficacy of HCR040 in Acute Respiratory Distress Syndrome","status":"COMPLETED","sponsor":"Histocell, S.L.","startDate":"2019-12-10","conditions":"Acute Respiratory Distress Syndrome","enrollment":26},{"nctId":"NCT05017298","phase":"PHASE2","title":"Clinical Study for Subjects With COVID-19 Using Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells","status":"NOT_YET_RECRUITING","sponsor":"Celltex Therapeutics Corporation","startDate":"2024-11-01","conditions":"Corona Virus Infection, Covid19","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Adipose-Derived Mesenchymal Stem Cells","genericName":"Adipose-Derived Mesenchymal Stem Cells","companyName":"Steminent Biotherapeutics Inc.","companyId":"steminent-biotherapeutics-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Adipose-derived mesenchymal stem cells modulate immune responses and promote tissue repair through paracrine signaling and differentiation into multiple cell types. Used for Orthopedic injuries, Autoimmune diseases, Wound healing.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}